1. Home
  2. ASBPW vs GPRO Comparison

ASBPW vs GPRO Comparison

Compare ASBPW & GPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBPW
  • GPRO
  • Stock Information
  • Founded
  • ASBPW N/A
  • GPRO 2004
  • Country
  • ASBPW United States
  • GPRO United States
  • Employees
  • ASBPW N/A
  • GPRO N/A
  • Industry
  • ASBPW Biotechnology: Pharmaceutical Preparations
  • GPRO Industrial Machinery/Components
  • Sector
  • ASBPW Health Care
  • GPRO Consumer Discretionary
  • Exchange
  • ASBPW Nasdaq
  • GPRO Nasdaq
  • Market Cap
  • ASBPW N/A
  • GPRO N/A
  • IPO Year
  • ASBPW 2022
  • GPRO 2014
  • Fundamental
  • Price
  • ASBPW N/A
  • GPRO $0.53
  • Analyst Decision
  • ASBPW
  • GPRO Hold
  • Analyst Count
  • ASBPW 0
  • GPRO 1
  • Target Price
  • ASBPW N/A
  • GPRO $1.50
  • AVG Volume (30 Days)
  • ASBPW N/A
  • GPRO 5.5M
  • Earning Date
  • ASBPW N/A
  • GPRO 05-06-2025
  • Dividend Yield
  • ASBPW N/A
  • GPRO N/A
  • EPS Growth
  • ASBPW N/A
  • GPRO N/A
  • EPS
  • ASBPW N/A
  • GPRO N/A
  • Revenue
  • ASBPW N/A
  • GPRO $801,473,000.00
  • Revenue This Year
  • ASBPW N/A
  • GPRO N/A
  • Revenue Next Year
  • ASBPW N/A
  • GPRO $5.05
  • P/E Ratio
  • ASBPW N/A
  • GPRO N/A
  • Revenue Growth
  • ASBPW N/A
  • GPRO N/A
  • 52 Week Low
  • ASBPW N/A
  • GPRO $0.40
  • 52 Week High
  • ASBPW N/A
  • GPRO $1.98
  • Technical
  • Relative Strength Index (RSI)
  • ASBPW N/A
  • GPRO 33.90
  • Support Level
  • ASBPW N/A
  • GPRO $0.40
  • Resistance Level
  • ASBPW N/A
  • GPRO $0.55
  • Average True Range (ATR)
  • ASBPW 0.00
  • GPRO 0.06
  • MACD
  • ASBPW 0.00
  • GPRO 0.00
  • Stochastic Oscillator
  • ASBPW 0.00
  • GPRO 43.84

About ASBPW Aspire Biopharma Holdings Inc. Warrant

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: